AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2044644 — intervention group
Group type: EXPERIMENTAL
Intervention: Niacin
Number of subjects: 3908
Study 2044644 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3908
Study 7174412 — intervention group
Group type: EXPERIMENTAL
Intervention: VE (ventilatory index)
Number of subjects: 16
Study 7174412 — intervention group
Group type: EXPERIMENTAL
Intervention: VCO2 (ventilatory index)
Number of subjects: 16
Study 7174412 — intervention group
Group type: EXPERIMENTAL
Intervention: R (ventilatory index)
Number of subjects: 16
Study 7174412 — intervention group
Group type: EXPERIMENTAL
Intervention: VE/VO2 (ventilatory index)
Number of subjects: 16
Study 7174412 — intervention group
Group type: EXPERIMENTAL
Intervention: HLa (blood lactate concentration)
Number of subjects: 16
Study 31449735 — intervention group
Group type: EXPERIMENTAL
Intervention: Septo-RFA (septoplasty with radiofrequency ablation)
Number of subjects: 60
Study 31449735 — intervention group
Group type: COMPARATOR
Intervention: Septo-Sham (septoplasty with sham surgery)
Number of subjects: 60
Study 30099096 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily nitrate supplementation (70 mL beetroot juice, n = 20)
Number of subjects: 40
Study 30099096 — intervention group
Group type: COMPARATOR
Intervention: Placebo (70 mL nitrate-depleted beetroot juice, n = 20)
Number of subjects: 40
Study 27638636 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV)
Number of subjects: 77
Study 25455119 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health worker-led diabetes education and management intervention
Number of subjects: 180
Study 25455119 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 180
Study 22119338 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest-resistance TENS
Number of subjects: 0
Study 22119338 — intervention group
Group type: COMPARATOR
Intervention: Random TENS
Number of subjects: 0
Study 20010118 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric restriction plus aerobic exercise (CR + EX)
Number of subjects: 36
Study 20010118 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR)
Number of subjects: 36
Study 20010118 — intervention group
Group type: COMPARATOR
Intervention: Control (CO)
Number of subjects: 36
Study 16631281 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminiscence education program (2-hour session) followed by a 13-week implementation during community health practicum
Number of subjects: 64
Study 16631281 — intervention group
Group type: COMPARATOR
Intervention: None (no-treatment control group)
Number of subjects: 64
Study 16175011 — intervention group
Group type: EXPERIMENTAL
Intervention: Stenting plus abciximab
Number of subjects: 293
Study 16175011 — intervention group
Group type: COMPARATOR
Intervention: Thrombolysis (alteplase alone or alteplase plus abciximab)
Number of subjects: 293
Study 12420857 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 4.5 g total for 3 weeks (1 x 500 mg weekly for 3 days)
Number of subjects: 123
Study 12420857 — intervention group
Group type: COMPARATOR
Intervention: Clarithromycin 500 mg b.i.d. for 15 days
Number of subjects: 123
Study 12420857 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin for asymptomatic chlamydial prostatitis
Number of subjects: 123
Study 12420857 — intervention group
Group type: COMPARATOR
Intervention: Clarithromycin for asymptomatic chlamydial prostatitis
Number of subjects: 123
Study 9849710 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone-misoprostol abortion
Number of subjects: 1373
Study 9849710 — intervention group
Group type: COMPARATOR
Intervention: Surgical abortion
Number of subjects: 1373
Study 8546288 — intervention group
Group type: EXPERIMENTAL
Intervention: New lightweight device for detection of tracheal tube placement
Number of subjects: 0
Study 1978480 — intervention group
Group type: EXPERIMENTAL
Intervention: Remoxipride 50 mg single dose
Number of subjects: 10
Study 1978480 — intervention group
Group type: EXPERIMENTAL
Intervention: Remoxipride 50 mg, 100 mg, and 200 mg twice daily
Number of subjects: 10
Study 1978480 — intervention group
Group type: COMPARATOR
Intervention: Control group (young adults 19-36 years)
Number of subjects: 10
Study 349155 — intervention group
Group type: EXPERIMENTAL
Intervention: Rubidium chloride; dosage not specified; duration not specified
Number of subjects: 0
Study 349155 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 31872219 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 881
Study 31872219 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 881
Study 31872219 — intervention group
Group type: EXPERIMENTAL
Intervention: Third trimester 25(OH)D levels
Number of subjects: 881
Study 31262489 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower uromodulin (hazard ratio per two-fold higher)
Number of subjects: 2351
Study 31262489 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher α1m (hazard ratio)
Number of subjects: 2351
Study 31262489 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal increases in urine NGAL, IL-19, and YKL-40
Number of subjects: 2351
Study 31262489 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal increase in α1m
Number of subjects: 2351
Study 31262489 — intervention group
Group type: EXPERIMENTAL
Intervention: None of the five injury markers
Number of subjects: 2351
Study 28404154 — intervention group
Group type: COMPARATOR
Intervention: Interval appendicectomy
Number of subjects: 106
Study 28404154 — intervention group
Group type: EXPERIMENTAL
Intervention: Active observation
Number of subjects: 106
Study 25807814 — intervention group
Group type: EXPERIMENTAL
Intervention: Syndrome Differentiated Chinese Medicine Therapy
Number of subjects: 396
Study 25807814 — intervention group
Group type: COMPARATOR
Intervention: Losartan 50 mg/d
Number of subjects: 396
Study 21834863 — intervention group
Group type: EXPERIMENTAL
Intervention: Lingual gold onlay
Number of subjects: 24
Study 21834863 — intervention group
Group type: COMPARATOR
Intervention: Resilient mouth guard
Number of subjects: 24
Study 21834863 — intervention group
Group type: EXPERIMENTAL
Intervention: Screw-retained implant-supported full-arch casted titanium-resin prostheses
Number of subjects: 24
Study 20719873 — intervention group
Group type: EXPERIMENTAL
Intervention: Print-focused reading sessions
Number of subjects: 62
Study 20719873 — intervention group
Group type: COMPARATOR
Intervention: Picture-focused condition
Number of subjects: 62
Study 20719873 — intervention group
Group type: COMPARATOR
Intervention: Sound-focused condition
Number of subjects: 62
Study 19017277 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA)
Number of subjects: 50
Study 19017277 — intervention group
Group type: COMPARATOR
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 50
Study 16960172 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (200,000 IU)
Number of subjects: 81
Study 15554354 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnant women before delivery
Number of subjects: 19
Study 15554354 — intervention group
Group type: COMPARATOR
Intervention: Healthy nonpregnant women
Number of subjects: 19
Study 15554354 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnant women after delivery
Number of subjects: 19
Study 15554354 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonpregnant women)
Number of subjects: 19
Study 11318251 — intervention group
Group type: EXPERIMENTAL
Intervention: Worry about STD
Number of subjects: 522
Study 11318251 — intervention group
Group type: EXPERIMENTAL
Intervention: Worry about HIV
Number of subjects: 522
Study 10759235 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN‐alpha2b, 5 MU daily plus ribavirin
Number of subjects: 10
Study 10759235 — intervention group
Group type: COMPARATOR
Intervention: IFN‐alpha2b, 5 MU three times a week plus ribavirin
Number of subjects: 10
Study 10759235 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 10
Study 8797030 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymerase chain reaction (PCR) method
Number of subjects: 22
Study 8797030 — intervention group
Group type: EXPERIMENTAL
Intervention: Serological methods (complement fixation test and enzyme‐immunoassay)
Number of subjects: 22
Study 8797030 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid treatment
Number of subjects: 22
Study 8797030 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR method
Number of subjects: 22
Study 8797030 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant assays of PCR and Ab
Number of subjects: 22
Study 1569815 — intervention group
Group type: EXPERIMENTAL
Intervention: 13‐RED regimen (twice weekly rifampicin 600 mg, daily ethionamide 500 mg, dapsone 100 mg)
Number of subjects: 559
Study 1569815 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced dosage of ethionamide to 5 mg/k bodyweight in the RED group
Number of subjects: 559
Study 1569815 — intervention group
Group type: EXPERIMENTAL
Intervention: REC regimen (clofazimine 100 mg)
Number of subjects: 559
Study 6339294 — intervention group
Group type: EXPERIMENTAL
Intervention: halometasone/triclosan cream
Number of subjects: 220
Study 6339294 — intervention group
Group type: COMPARATOR
Intervention: fluocinolone acetonide/neomycin cream
Number of subjects: 220
Study 6339294 — intervention group
Group type: COMPARATOR
Intervention: fluprednylidene acetate/gentamicin/chlorohydroxyquinoline cream
Number of subjects: 220
Study 31009243 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance training with VR (Nintendo Wii Fit system™) for 1 week, 3 sessions
Number of subjects: 29
Study 31009243 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control Group)
Number of subjects: 29
Study 28069835 — intervention group
Group type: EXPERIMENTAL
Intervention: High-density multielectrode mapping (MEM)
Number of subjects: 20
Study 25217316 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-wedge osteotomy
Number of subjects: 50
Study 25217316 — intervention group
Group type: COMPARATOR
Intervention: Open-wedge osteotomy
Number of subjects: 50
Study 25223482 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin/cyclophosphamide followed by docetaxel with bevacizumab (8 infusions every 3 weeks)
Number of subjects: 1948
Study 25223482 — intervention group
Group type: COMPARATOR
Intervention: Epirubicin/cyclophosphamide followed by docetaxel without bevacizumab
Number of subjects: 1948
Study 25223482 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel with everolimus (5 mg/day)
Number of subjects: 1948
Study 25223482 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel without everolimus
Number of subjects: 1948
Study 21707775 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold air analgesia
Number of subjects: 43
Study 21707775 — intervention group
Group type: COMPARATOR
Intervention: No cold air analgesia (control)
Number of subjects: 43
Study 19682909 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-filled soft brace
Number of subjects: 73
Study 19682909 — intervention group
Group type: COMPARATOR
Intervention: Hard brace
Number of subjects: 73
Study 17012341 — intervention group
Group type: EXPERIMENTAL
Intervention: Active deep brain stimulation (DBS)
Number of subjects: 5
Study 17012341 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 5
Study 15774257 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg levofloxacin
Number of subjects: 400
Study 15774257 — intervention group
Group type: EXPERIMENTAL
Intervention: 320/1600 mg trimethoprim/sulfamethoxazole (TMP/SMZ)
Number of subjects: 400
Study 15774257 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic prophylaxis (control group)
Number of subjects: 400
Study 11777506 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate pushing at complete dilatation
Number of subjects: 252
Study 11777506 — intervention group
Group type: COMPARATOR
Intervention: Rest period before pushing
Number of subjects: 252
Study 9660087 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG/human menopausal gonadotropin treatment in IHH patients
Number of subjects: 37
Study 9660087 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone treatment in Klinefelter's syndrome patients
Number of subjects: 37
Study 9660087 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal men)
Number of subjects: 37
Study 7706066 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic touch
Number of subjects: 40
Study 7706066 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (no therapeutic touch)
Number of subjects: 40
Study 2515720 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline 10 mg per day
Number of subjects: 38
Study 2515720 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 31392518 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral access
Number of subjects: 150
Study 31392518 — intervention group
Group type: COMPARATOR
Intervention: Central access
Number of subjects: 150
Study 31392518 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall complications
Number of subjects: 150
Study 28710052 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet Nutritional Intervention (MDNI) for 12 months
Number of subjects: 1000
Study 28710052 — intervention group
Group type: COMPARATOR
Intervention: Usual care for 12 months
Number of subjects: 1000
Study 28710052 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet Nutritional Intervention (MDNI) for 6 months (after crossover)
Number of subjects: 1000
Study 28710052 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-sustained continuation phase for 6 months (after crossover)
Number of subjects: 1000
Study 28710052 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in body weight, body composition, and other cardiometabolic risk markers
Number of subjects: 1000
Study 28710052 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported dietary habits and biomarkers of dietary adherence
Number of subjects: 1000
Study 25110844 — intervention group
Group type: EXPERIMENTAL
Intervention: PA plus RTR intervention delivered by RTR volunteers
Number of subjects: 76
Study 25110844 — intervention group
Group type: COMPARATOR
Intervention: Contact control (RTR control)
Number of subjects: 76
Study 24228901 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle changes (modified Mediterranean diet and moderate physical exercise for 20 weeks)
Number of subjects: 108
Study 24228901 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle changes
Number of subjects: 108
Study 24228901 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine (100 ml for women, 200 ml for men daily)
Number of subjects: 108
Study 24228901 — intervention group
Group type: COMPARATOR
Intervention: Any intervention
Number of subjects: 108
Study 21450674 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 or 40 mg
Number of subjects: 1000
Study 21450674 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 1000
Study 21450674 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants reaching 2.0 mmol/l LDL-C
Number of subjects: 1000
Study 19335418 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus 0.03% ointment (once-daily application)
Number of subjects: 53
Study 19335418 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus 0.03% ointment (twice-daily application)
Number of subjects: 53
Study 16455435 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi intervention
Number of subjects: 0
Study 15236620 — intervention group
Group type: EXPERIMENTAL
Intervention: Amprenavir (APV) boosted with low-dose ritonavir (RTV, 100 mg bid)
Number of subjects: 163
Study 15236620 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) protease inhibitors (PIs) with or without low-dose RTV
Number of subjects: 163
Study 11215552 — intervention group
Group type: EXPERIMENTAL
Intervention: Family economic support
Number of subjects: 203
Study 11215552 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiving hours
Number of subjects: 203
Study 11215552 — intervention group
Group type: EXPERIMENTAL
Intervention: Informal support
Number of subjects: 203
Study 9328113 — intervention group
Group type: EXPERIMENTAL
Intervention: CD28 costimulation
Number of subjects: 0
Study 9328113 — intervention group
Group type: EXPERIMENTAL
Intervention: CD28 costimulation in lymphocyte cultures with HIV-1 gp160 or p24
Number of subjects: 0
Study 9328113 — intervention group
Group type: COMPARATOR
Intervention: CD3-mediated responses
Number of subjects: 0
Study 8252662 — intervention group
Group type: EXPERIMENTAL
Intervention: Parnaparin
Number of subjects: 29
Study 3302764 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 91
Study 3302764 — intervention group
Group type: COMPARATOR
Intervention: Pentazocine
Number of subjects: 91
Study 30314506 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative TMD treatment with a maximum of 18 sessions within 9 weeks
Number of subjects: 0
Study 30314506 — intervention group
Group type: COMPARATOR
Intervention: Delayed-start group (no treatment for 9 weeks)
Number of subjects: 0
Study 29126228 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Frequency Spinal Cord Stimulation (HF SCS)
Number of subjects: 78
Study 29126228 — intervention group
Group type: COMPARATOR
Intervention: Conventional Frequency Spinal Cord Stimulation (CF SCS)
Number of subjects: 78
Study 26261987 — intervention group
Group type: COMPARATOR
Intervention: Psychological first aid and psychoeducation at discharge from hospital (Group B)
Number of subjects: 225
Study 26261987 — intervention group
Group type: COMPARATOR
Intervention: Psychological first aid and psychoeducation at discharge and a second intervention one month later based on cognitive behavioural principles (Group C)
Number of subjects: 225
Study 26261987 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Group A)
Number of subjects: 225
Study 24075505 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocaloric high fat low carbohydrate diet (HFLC) for 12 weeks
Number of subjects: 55
Study 24075505 — intervention group
Group type: COMPARATOR
Intervention: Low fat high carbohydrate diet (LFHC) for 12 weeks
Number of subjects: 55
Study 21377273 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-102 4 mg twice a day
Number of subjects: 36
Study 21377273 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 18755719 — intervention group
Group type: EXPERIMENTAL
Intervention: GEWF solution preparation
Number of subjects: 120
Study 18755719 — intervention group
Group type: COMPARATOR
Intervention: Conventional preparation
Number of subjects: 120
Study 17205815 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Wuzi Yanzong Granule (WYG)
Number of subjects: 36
Study 17205815 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 36
Study 14693069 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy based on chemosensitivity testing in nude mouse assay (Group I)
Number of subjects: 130
Study 14693069 — intervention group
Group type: COMPARATOR
Intervention: Standard regimen adjuvant chemotherapy (Group C) - cyclophosphamide (CTX) 600 mg/m² d1 + Adriamycin (ADM) 40 mg/m² d1 + cisplatin (DDP) 20 mg/m² d1-5
Number of subjects: 130
Study 10751105 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated altitude of 2650 m for 5 nights (8-11 hours per night)
Number of subjects: 6
Study 10751105 — intervention group
Group type: COMPARATOR
Intervention: Control group at near-sea-level conditions (600 m altitude)
Number of subjects: 6
Study 10751105 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsequent hypoxic exposures after 3 nights at near sea level
Number of subjects: 6
Study 10751105 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall conclusion
Number of subjects: 6
Study 8642852 — intervention group
Group type: EXPERIMENTAL
Intervention: Idarubicin (IDA: 8 mg/m2/day, i.v. bolus for 5 days)
Number of subjects: 220
Study 8642852 — intervention group
Group type: COMPARATOR
Intervention: Daunorubicin (DNR: 50 mg/m2/day, i.v. bolus for 3 days)
Number of subjects: 220
Study 1515246 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservation technique
Number of subjects: 197
Study 1515246 — intervention group
Group type: COMPARATOR
Intervention: Mastectomy
Number of subjects: 197
Study 6230249 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxitropium bromide 200 micrograms
Number of subjects: 20
Study 6230249 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 80 micrograms
Number of subjects: 20
Study 6230249 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 27768615 — intervention group
Group type: COMPARATOR
Intervention: etafilcon A (ACUVUE 2, control)
Number of subjects: 36
Study 27768615 — intervention group
Group type: EXPERIMENTAL
Intervention: lotrafilcon B (Air Optix Aqua)
Number of subjects: 36
Study 27768615 — intervention group
Group type: EXPERIMENTAL
Intervention: comfilcon A (Biofinity)
Number of subjects: 36
Study 27768615 — intervention group
Group type: COMPARATOR
Intervention: etafilcon A vs lotrafilcon B
Number of subjects: 36
Study 27768615 — intervention group
Group type: COMPARATOR
Intervention: etafilcon A vs comfilcon A
Number of subjects: 36
Study 27768615 — intervention group
Group type: COMPARATOR
Intervention: etafilcon A
Number of subjects: 36
Study 26641557 — intervention group
Group type: EXPERIMENTAL
Intervention: OSNAP Initiative (intervention group)
Number of subjects: 402
Study 26641557 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 402
Study 24233069 — intervention group
Group type: EXPERIMENTAL
Intervention: 22-gauge needle
Number of subjects: 93
Study 24233069 — intervention group
Group type: COMPARATOR
Intervention: 25-gauge needle
Number of subjects: 93
Study 24233069 — intervention group
Group type: EXPERIMENTAL
Intervention: Both needles
Number of subjects: 93
Study 24233069 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-LP headache
Number of subjects: 93
Study 23517382 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous noncultured epidermal cell suspension (NCES)
Number of subjects: 30
Study 23517382 — intervention group
Group type: COMPARATOR
Intervention: Autologous noncultured extracted hair follicle outer root sheath cell suspension (NCORSHFS)
Number of subjects: 30
Study 23517382 — intervention group
Group type: EXPERIMENTAL
Intervention: Both NCES and NCORSHFS
Number of subjects: 30
Study 20528823 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg/d for 3 days)
Number of subjects: 32
Study 20528823 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32